Pharma MSMEs lament impact of inverted duty under GST 2.0
Fast facts
- Category: Asia
- Language: EN
- Published: 2026-05-02 13:36 UTC
- Sources: The Hindu
Small and medium pharmaceutical manufacturers expressed concerns that the recent inverted duty structure imposed by GST 2.0 is harming their operations. Industry body Pharmexcil is gathering input to submit a collective representation to the ministry, highlighting the need for structural reforms.
Why it matters
- This update can influence the Asia agenda over the next 24-48 hours.
- It is based on 1 source, which helps cross-check key claims quickly.
- Watch follow-up statements and market/public response to assess real impact.